Charm Therapeutics: Charm Therapeutics gains investment from NVentures to develop therapeutics for cancer
Charm Therapeutics has announced investment from NVentures â NVIDIAâs venture investment arm. This represents a major milestone for Charm and means it will be able to deliver more on its research and development (R&D) activities for novel oncology medicines.
Read full article »
Charm Therapeutics is an England-based biotechnology company that researches and develops novel small-molecule therapeutics for the treatment of cancer.
Read more